Advancing Diagnostic Approaches for TMJ Diseases and Disorders
The Third Scientific Meeting of The TMJ Association
Co-sponsored by the Office of Rare Diseases, National Institute of Bioimaging and Bioengineering, Office of Research on Women's Health, and the National Institute of Dental and Craniofacial Research
May 5-7, 2004
Hyatt Regency Bethesda, Bethesda, Maryland
Purpose of Meeting:
While the focus is on applications of new technology to temporomandibular disorders, many advances come from studies related to other forms of musculoskeletal injuries and diseases. Therefore, all scientific investigators in musculoskeletal research would be expected to contribute to this scientific meeting and gain new insights regarding diagnostic approaches that may be used experimentally and clinically. We anticipate that all attendees will benefit greatly from the diversity and planned interactions among the multidisciplinary group of participants.
Educational Objectives:
- Learn the current approaches used for the diagnosis of TMJ diseases and disorders.
- Learn how new and emerging diagnostic technologies can be applied to the TM joint.
- Understand the complexity of TMJ diseases and disorders.
- Understand the limitations in predicting outcomes of specific treatments for individuals.
- Become aware of the NIH recommendations for conservative treatments, with irreversible treatment selected as a last resort.
Who Should Attend:
Physicians, dentists, federal health agency officials, medical scientists, bioengineers, and medical imaging specialists should attend this meeting. The meeting will also benefit TMJ patients who are interested in learning about the progress in diagnosing and treating TMJ.
Topics:
TMJ Diseases and Disorders and the Need for Innovative Diagnostic Tools
- Stephen B. Milam, D.D.S., Ph.D., University of Texas Health Science Center, San Antonio, TX
- Christian S. Stohler, D.M.D., Dr. Med. Dent., University of Maryland Dental School, Baltimore, MD
Current and Future Methodologies of Imaging for TMJ Diseases and Disorders (Including X-Ray, MRI, fMRI, PET, NMRI, Ultrasound, and Thermography Imaging)
- Rudiger Emshoff, M.D., D.M.D., University of Innsbruck, Austria
- James S. Hyde, Ph.D., Medical College of Wisconsin, Milwaukee, WI
- Sigvard Kopp, D.D.S, Ph.D., Institute of Odontology at Karolinska Institutet, Sweden
- Kieran Murphy, M.D., Johns Hopkins Hospital, Baltimore, MD
- Russell S. Richardson, Ph.D., University of California San Diego, La Jolla, CA
Methodologies for Brain Imaging Related to TMJ Diseases and Disorders
- Robert C. Coghill, Ph.D., Wake Forest University School of Medicine, Winston-Salem, NC
- Joel D. Greenspan, Ph.D., University of Maryland, Baltimore, MD
- Jon-Kar Zubieta, M.D., Ph.D., University of Michigan, Ann Arbor, MI
Applications of Nanotechnologies for Imaging and Targeting Joint Therapy
- Thomas F. Budinger, M.D., Ph.D., University of California, Berkeley, CA
- Samuel A. Wickline, M.D., Washington University School of Medicine, St. Louis, MO
Clinical Research Use of Imaging Technologies for TMJ Diseases and Disorders
- Jos Dibbets, D.D.S., Ph.D., Philipps University, Marburg, Germany
- Tore A. Larheim, D.D.S., Ph.D., University of Oslo, Oslo, Norway
- Carl S. Winalski, M.D., Brigham and Women's Hospital, Boston, MA
Computational Approaches for Modeling of TM Joint Mechanics and Morphology
- Luigi M. Gallo, P.D., University of Zurich, Switzerland
- Arthur W. English, Ph.D., Emory University School of Medicine, Atlanta, GA
- Susan W. Herring, Ph.D., University of Washington, Seattle, WA
- Peter Hunter, D. Phil., University of Auckland, New Zealand
- Andrew Pullinger, D.D.S., M.Sc., University of California Los Angeles, Los Angeles, CA
Interactions Between Technical and Applied Users to Develop Recommendations for Diagnostic Criteria for TMJ Diseases and Disorders
- David E. Altobelli, D.M.D., M.D., DEKA Research and Development, Manchester, NH
- Thomas F. Budinger, M.D., Ph.D., University of California, Berkeley, CA
- Stephen Feinberg, Ph.D., D.D.S. M.S., University of Michigan Medical Center, Ann Arbor, MI
- Stephen L. Gordon, Ph.D., Cognate Therapeutics, Bethesda, MD
- Sigvard Kopp, D.D.S., Ph.D., Institute of Odontology at Karolinska Institutet, Sweden
- Stephen B. Milam, D.D.S., Ph.D. University of Texas Health Science Center, San Antonio, TX
- John Watson, Ph.D., University of California San Diego, La Jolla, CA
- Randall Wilk, D.D.S., Ph.D., M.D., Louisiana State University, LA
- Jon-Kar Zubieta, M.D., Ph.D., University of Michigan, Ann Arbor, MI
Meeting Organizers:
- Allen W. Cowley, Jr., Ph.D., Medical College of Wisconsin (Chair)
- Shu Chien, M.D., Ph.D., University of California
- Ronald Dubner, D.D.S., Ph.D., University of Maryland Dental School
- James S. Hyde, Ph.D., Medical College of Wisconsin
- Julie Glowacki, Ph.D., Harvard Medical School, Harvard Dental School of Dental Med.
- Stephen L. Gordon, Ph.D., Cognate Therapeutics
- Stephen B. Milam, D.D.S., Ph.D., University of Texas Health Science Center
- Christian S. Stohler, D.M.D., Dr. Med. Dent., University of Maryland Dental School
- John Watson, Ph.D., University of California San Diego, La Jolla, CA
Accreditation Statement:
Persons attending the scientific meeting are eligible to receive up to 12.35 hours of continuing dental education credit through the National Institute of Dental and Craniofacial Research.
 This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Medical College of Wisconsin and The TMJ Association. The Medical College of Wisconsin (MCW) is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit Statement:
The Medical College of Wisconsin designates this educational activity for a maximum of 12.75 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
back to top
Last Updated 04-19-04
|
